Open Site Navigation
The Science

GEM Pharma has established a robust and versatile drug discovery and development platform based on proprietary technologies, broad licenses to fundamental intellectual property and extensive scientific expertise after more than four decades working on influencing the production level of protein in the cell to achieve healing via regulation of gene expression without interfering with genetics.

Contact Us

Thanks for submitting!

The Products

GEM Pharma products cover a wide range of inflammatory conditions, and future developments are expanding the range further. All products are based on Gene Expression Modification and have a solid scientific and clinical base.

Eye Drops

Skin Care

Nasal Spray

Vaginal Moisturizer

TREAT INFLAMMATION
VIA mRNA CALIBRATION

GEM Pharma is a pharmaceutical company that develops and brings to market safe, affordable medications for inflammatory conditions based on the unique Gene Expression Modification platform.

About Us

GEM Pharma is a spinoff of Resdevco Ltd. a pharmaceutical research company that was established over 40 years ago. The pioneering research was developed by Prof. Shabtay Dikstein (Prof. Emeritus) of the Hebrew University. Recognized by the university and internationally as a creative, groundbreaking inventor and innovator. The strength of GEM Pharma lies not only on the innovative and groundbreaking G.E.M platform but also on the strong network of professionals that has been built over the last three decades.

Erez Meltzer

EXECUTIVE CHAIRMAN

Dani Shomron

CHIEF EXECUTIVE OFFICER

Dr. L. Szabo

DIRECTOR OF REGISTRATION AND CLINICAL TRIALS

Dr. H. Kiss

SCIENTIFIC DIRECTOR OPHTHALMOLOGY

Dr. G. Bartus

QUALITY DIRECTOR AND FORMULATION

Pipeline

Our platform is potentially applicable to a broad range of diseases caused by insufficient protein production or where production of proteins can modify the disease. The depth and versatility of our technologies enable us to address conditions in virtually any therapeutic area.